Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 646853, 8 pages
http://dx.doi.org/10.1155/2015/646853
Research Article

Expression of MMP-9 and VEGF in Meningiomas and Their Correlation with Peritumoral Brain Edema

1Department of Medical Pathomorphology, Medical University of Bialystok, Ulica Waszyngtona 13, 15-269 Bialystok, Poland
2Department of Neurosurgery, Medical University of Bialystok, Ulica Marii Skłodowskiej-Curie 24A, 15-276 Bialystok, Poland

Received 22 August 2014; Revised 4 February 2015; Accepted 13 February 2015

Academic Editor: Gang Liu

Copyright © 2015 Joanna Reszec et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Abdelzaher, N. M. F. El Deeb, A. G. Gowil, and A. Yehya, “Biological and demographic profile of meningiomas in a cohort of egyptian patients: impact on tumor recurrence,” The Scientific World Journal, vol. 2013, Article ID 375139, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Barresi, C. Alafaci, M. Caffo, G. Barresi, and G. Tuccari, “Clinicopathological characteristics, hormone receptor status and matrix metallo-proteinase-9 (MMP-9) immunohistochemical expression in spinal meningiomas,” Pathology Research and Practice, vol. 208, no. 6, pp. 350–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Beltran, K. Matiasek, L. de Risio, A. de Stefani, A. L. Feliu-Pascual, and L. A. Matiasek, “Expression of MMP-2 and MMP-9 in benign canine rostrotentorial meningiomas is not correlated to the extent of peritumoral edema,” Veterinary Pathology, vol. 50, no. 6, pp. 1091–1098, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. F. Chambers and L. M. Matrisian, “Changing views of the role of matrix metalloproteinases in metastasis,” Journal of the National Cancer Institute, vol. 89, no. 17, pp. 1260–1270, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Kwon, C. O. Sung, S. Y. Kang, I.-G. Do, and Y.-L. Suh, “Differential expression of extracellular matrix-related genes in rare variants of meningioma,” Human Pathology, vol. 44, no. 2, pp. 260–268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Markovic, V. Antunovic, S. Milenkovic, and N. Zivkovic, “Prognostic value of peritumoral edema and angiogenesis in intracranial meningioma surgery,” Journal of Balkan Union of Oncology, vol. 18, no. 2, pp. 430–436, 2013. View at Google Scholar · View at Scopus
  7. J. Reszec, A. Hermanowicz, R. Rutkowski, P. Bernaczyk, Z. Mariak, and L. Chyczewski, “Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema,” Journal of Neuro-Oncology, vol. 115, no. 1, pp. 119–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Tamiya, Y. Ono, K. Matsumoto, and T. Ohmoto, “Peritumoral brain edema in intracranial meningiomas: effects of radiological and histological factors,” Neurosurgery, vol. 49, no. 5, pp. 1046–1052, 2001. View at Google Scholar · View at Scopus
  9. E. Iwado, T. Ichikawa, H. Kosaka et al., “Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas,” Neuropathology, vol. 32, no. 6, pp. 638–646, 2012. View at Publisher · View at Google Scholar
  10. P. Dharmalingam, V. R. Roopesh Kumar, and S. K. Verma, “Vascular endothelial growth factor expression and angiogenesis in various grades and subtypes of meningioma,” Indian Journal of Pathology and Microbiology, vol. 56, no. 4, pp. 349–354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. H. Hawasli, J. B. Rubin, D. D. Tran et al., “Antiangiogenic agents for nonmalignant brain tumors,” Journal of Neurological Surgery, Part B: Skull Base, vol. 74, no. 3, pp. 136–141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Q. Huang, S.-L. Zhao, X.-Y. Tian, B. Li, and Z. Li, “Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma,” International Journal of Medical Sciences, vol. 10, no. 3, pp. 276–285, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Pistolesi, L. Boldrini, S. Gisfredi et al., “Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study,” Neuropathology and Applied Neurobiology, vol. 30, no. 2, pp. 118–125, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak, “Vascular endothelial growth factor (VEGF) and its receptors,” The FASEB Journal, vol. 13, no. 1, pp. 9–22, 1999. View at Google Scholar · View at Scopus
  15. C. Pfister, H. Pfrommer, M. S. Tatagiba, and F. Roser, “Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro,” British Journal of Cancer, vol. 107, no. 10, pp. 1702–1713, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Jung, K.-S. Moon, S.-T. Kim et al., “Increased expression of intracystic matrix metalloproteinases in brain tumors: relationship to the pathogenesis of brain tumor-associated cysts and peritumoral edema,” Journal of Clinical Neuroscience, vol. 14, no. 12, pp. 1192–1198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. H. Paek, D. G. Kim, C.-K. Park et al., “The role of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in microcystic meningiomas,” Oncology Reports, vol. 16, no. 1, pp. 49–56, 2006. View at Google Scholar · View at Scopus
  18. D. Nassehi, “Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema,” Danish Medical Journal, vol. 60, no. 4, Article ID B4626, 2013. View at Google Scholar · View at Scopus
  19. J. Hou, V. R. Kshettry, W. R. Selman, and N. C. Bambakidis, “Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy,” Neurosurgical Focus, vol. 35, no. 6, article E2, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S. H. Lee, Y. S. Lee, Y. G. Hong, and C. S. Kang, “Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas,” APMIS, vol. 122, no. 1, pp. 16–24, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Preusser, M. Hassler, P. Birner et al., “Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches,” Clinical Neuropathology, vol. 31, no. 5, pp. 352–360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Jensen and J. Lee, “Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation,” Neurosurgery, vol. 71, no. 1, pp. 146–156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Salokorpi, S. Yrjänä, H. Tuominen et al., “Expression of VEGF and collagen XVIII in meningiomas: correlations with histopathological and MRI characteristics,” Acta Neurochirurgica, vol. 155, no. 6, pp. 989–996, 2013. View at Publisher · View at Google Scholar · View at Scopus